Outpatient Management of Hypotension

Initial Assessment and Management

The American College of Cardiology recommends testing for orthostatic hypotension by measuring blood pressure after 5 minutes of sitting or lying, then at 1 and 3 minutes after standing, with a drop of ≥20 mmHg systolic or ≥10 mmHg diastolic defining orthostatic hypotension 3, 1
Medication-induced hypotension is the most common cause, and reviewing and discontinuing or reducing culprit medications including diuretics, vasodilators, alpha-blockers, and antihypertensives is recommended 2
Volume depletion from dehydration, blood loss, or inadequate intake should be addressed 1
Alcohol consumption causes both direct CNS effects and volume depletion, and should be considered as a potential cause 2

Increasing fluid intake to 2-3 liters daily, unless contraindicated by heart failure, is recommended 1, 2
Increasing salt consumption to 6-9g daily, if not contraindicated, is also recommended 1, 2
Acute water ingestion of ≥480 mL provides temporary relief with peak effect at 30 minutes, and can raise systolic blood pressure by >30 mmHg in many patients 1, 2
Teaching leg crossing, squatting, stooping, and muscle tensing during symptomatic episodes is recommended 1, 2
Implementing gradual staged movements with postural changes is also recommended 2
Using compression garments including thigh-high stockings and abdominal binders to reduce venous pooling is recommended 1, 2
Elevating the head of bed by 10 degrees during sleep to prevent nocturnal polyuria and supine hypertension is recommended 2
Eating smaller, more frequent meals to reduce postprandial hypotension is recommended 1, 2
Encouraging regular physical activity to avoid deconditioning is recommended 2

Midodrine is the preferred first-line medication, starting with 2.5-5mg three times daily, with the last dose taken at least 3-4 hours before bedtime to avoid supine hypertension 1, 2
Fludrocortisone is an alternative first-line medication, starting with 0.05-0.1mg once daily, titrated to 0.1-0.3mg daily based on response 1, 2
Droxidopa is FDA-approved for neurogenic orthostatic hypotension, particularly effective in Parkinson's disease, pure autonomic failure, and multiple system atrophy 1, 2
Combining midodrine with fludrocortisone may be considered for patients not responding to monotherapy 2
Pyridostigmine may be beneficial for refractory orthostatic hypotension in elderly patients who have not responded to other treatments, with fewer side effects than alternatives 2

For patients with hypertension and orthostatic hypotension, switching blood pressure-lowering medications that worsen orthostatic hypotension to alternative therapy rather than simply reducing doses is recommended 3, 2
Consider long-acting dihydropyridine calcium channel blockers or RAS inhibitors as first-line therapy for these patients 2
Pursuing non-pharmacological approaches as first-line treatment is recommended 3
Assessing for cardiovascular autonomic neuropathy in diabetic patients is recommended 2
Considering alpha-lipoic acid for painful diabetic neuropathy, which may benefit autonomic function, is recommended 2
Using midodrine cautiously in diabetic patients is recommended 2
If blood pressure drops with progressing frailty in elderly and frail patients (≥85 years), consider deprescribing blood pressure-lowering medications and other drugs that reduce blood pressure (sedatives, alpha-blockers) 3

Reassessing within 1-2 weeks after initiating or changing medications is recommended 2
Monitoring blood pressure in both supine and standing positions to balance symptom relief against supine hypertension risk is recommended 2
The therapeutic goal is minimizing postural symptoms, not restoring normotension 1, 2